Industry News

Curated for Orthogate.org Members EXECUTIVE SUMMARY SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™ Extending Compromised Bone Platform Beyond Pelvis: Reported by OrthoSpineNews, SI-BONE secured FDA 510(k) clearance for the iFuse Granite Onyx™ System,...

Curated for Orthogate.org Members EXECUTIVE SUMMARY Smith+Nephew Launches EVOS◊ PELVIC Plating System at OTA 2026 Annual Meeting: Reported by OrthoSpineNews, Smith+Nephew commercially introduced its anatomically pre-contoured EVOS◊ PELVIC Plating System at OTA 2026,...

Curated for Orthogate.org Members EXECUTIVE SUMMARY OrthAlign Surpasses 500,000 Joint Replacement Procedures Worldwide: Reported by OrthoSpineNews, OrthAlign celebrated over 500,000 joint replacement procedures performed across more than twenty countries with its Lantern®...

Curated for Orthogate.org Members EXECUTIVE SUMMARY Theragen Unveils Real-World Evidence at SMISS 2026 Identifying Predictors of Recovery Following Spinal Fusion with ActaStim-S: As presented at the SMISS 2026 Annual Forum and reported by OrthoSpineNews, machine learning models...

Curated for Orthogate.org Members EXECUTIVE SUMMARY Smith+Nephew Achieves First Surgical Case with LANDMARK™ Total Knee System: As reported by OrthoSpineNews, Smith+Nephew received FDA 510(k) clearance (K261462) and completed the first surgical case utilizing its...

Curated for Orthogate.org Members EXECUTIVE SUMMARY Advita Ortho Introduces Axis Clinical Research Platform: As reported by OrthoSpineNews, Advita Ortho launched Axis, a surgeon-facing clinical research platform synthesizing 20+ years of multicenter shoulder arthroplasty...

Curated for Orthogate.org Members EXECUTIVE SUMMARY Zimmer Biomet Spotlights ROSA Shoulder and Signature Vision Navigation at ICSES 2026: As reported by OrthoSpineNews, Zimmer Biomet showcased its comprehensive shoulder portfolio featuring the ROSA® Shoulder System for...

Curated for Orthogate.org Members EXECUTIVE SUMMARY Synergy Spine Solutions Highlights Superior 2-Year IDE Synergy Disc Outcomes Over ACDF: As reported by OrthoSpineNews, two-year IDE clinical trial data presented at SMISS demonstrated an 87.1% composite success rate for the...